Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.23B |
| 2 |
Merck
MRK
|
$1B |
| 3 |
Abbott
ABT
|
$991M |
| 4 |
Gilead Sciences
GILD
|
$966M |
| 5 |
Amazon
AMZN
|
$920M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$2.75B |
| 2 |
Morgan Stanley
MS
|
$909M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$881M |
| 4 |
Charles Schwab
SCHW
|
$734M |
| 5 |
Arista Networks
ANET
|
$726M |
Sector Composition
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.45% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.07% |
| 5 | Consumer Discretionary | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
ResMed
RMD
$40.6B
| $359K | ﹤0.01% |
1,643
-2,219
| -57% | -$485K |
|
1627
Ultrapar
UGP
$4.17B
| $358K | ﹤0.01% |
91,182
-31,240
| -26% | -$123K |
|
1628
Regency Centers
REG
$13.4B
| $358K | ﹤0.01% |
+5,799
| New | +$358K |
|
1629
Ambac
AMBC
$422M
| $354K | ﹤0.01% |
24,839
| – | – |
|
1630
Western Digital
WDC
$31.9B
| $351K | ﹤0.01% |
12,246
+3,516
| +40% | +$101K |
|
1631
Zimmer Biomet
ZBH
$20.9B
| $340K | ﹤0.01% |
+2,333
| New | +$340K |
|
1632
Expedia Group
EXPE
$26.6B
| $332K | ﹤0.01% |
3,034
-16,856
| -85% | -$1.84M |
|
|
PARA
1633
DELISTED
Paramount Global Class B
PARA
| $332K | ﹤0.01% |
20,848
-89,648
| -81% | -$1.43M |
|
1634
Royal Caribbean
RCL
$95.7B
| $331K | ﹤0.01% |
3,190
-5,122
| -62% | -$531K |
|
1635
GE HealthCare
GEHC
$34.6B
| $330K | ﹤0.01% |
+4,068
| New | +$330K |
|
1636
Citizens Financial Services
CZFS
$295M
| $327K | ﹤0.01% |
4,481
-1,279
| -22% | -$93.4K |
|
1637
Lexicon Pharmaceuticals
LXRX
$396M
| $325K | ﹤0.01% |
142,006
-9,487
| -6% | -$21.7K |
|
1638
Bio-Rad Laboratories Class A
BIO
$8B
| $325K | ﹤0.01% |
856
-1,444
| -63% | -$547K |
|
1639
Marathon Digital Holdings
MARA
$5.63B
| $317K | ﹤0.01% |
22,898
-11,296
| -33% | -$157K |
|
1640
Boston Properties
BXP
$12.2B
| $316K | ﹤0.01% |
+5,483
| New | +$316K |
|
1641
Bit Digital
BTBT
$807M
| $313K | ﹤0.01% |
+77,154
| New | +$313K |
|
1642
Generation Bio
GBIO
$40.3M
| $308K | ﹤0.01% |
+5,597
| New | +$308K |
|
1643
Tower Semiconductor
TSEM
$7.07B
| $307K | ﹤0.01% |
8,341
-53,253
| -86% | -$1.96M |
|
1644
iShares Russell Mid-Cap ETF
IWR
$44.6B
| $307K | ﹤0.01% |
4,200
| – | – |
|
1645
Qorvo
QRVO
$8.61B
| $305K | ﹤0.01% |
2,991
-3,241
| -52% | -$331K |
|
1646
New Oriental
EDU
$7.98B
| $303K | ﹤0.01% |
7,664
-321,011
| -98% | -$12.7M |
|
1647
iShares MSCI Saudi Arabia ETF
KSA
$577M
| $301K | ﹤0.01% |
7,290
| – | – |
|
|
GRVY
1648
GRAVITY
GRVY
$444M
| $301K | ﹤0.01% |
4,284
| – | – |
|
1649
Sabesp
SBS
$15.8B
| $299K | ﹤0.01% |
25,292
-401
| -2% | -$4.75K |
|
1650
Lear
LEA
$5.91B
| $299K | ﹤0.01% |
2,082
+313
| +18% | +$44.9K |
|